FutureFuel (FF) Q2 2025 earnings summary

Executive summary

• Revenue declined 51% year-over-year to $35.7M for Q2 2025, with a net loss of $10.4M versus net income of $9.6M in Q2 2024, driven by market uncertainty and operational disruptions in biofuels.

• Adjusted EBITDA for Q2 2025 was $(9.8)M, compared to $6.9M in Q2 2024; six-month adjusted EBITDA was $(25.9)M versus $14.0M last year.

• Both chemical and biofuel segments experienced significant revenue and gross profit declines due to extended plant turnaround and unfavorable market conditions.

• Biodiesel production was idled in June/July 2025, resulting in a reduction in force of 75 employees, as high feedstock prices led to negative margins.

• Chemicals segment expanded its project pipeline and expects new production by Q4 2025/Q1 2026.

Financial highlights

• Q2 2025 revenue: $35.7M, down from $72.4M in Q2 2024; six-month revenue: $53.2M, down from $130.7M year-over-year.

• Net loss for Q2 2025: $10.4M; six-month net loss: $28.1M, compared to net income of $13.9M for the same period last year.

• Operating loss for Q2 2025: $11.9M; for six months: $30.8M.

• Gross loss for Q2 2025 was $8.8M, compared to gross profit of $8.7M in Q2 2024.

• Cash and cash equivalents at June 30, 2025, were $95.2M, down from $109.5M at year-end 2024.

Outlook and guidance

• The Budget Reconciliation Act of 2025 extended the clean fuel production credit (CFPC) through 2029 and reinstated the Small Agri-Biodiesel Producers Tax Credit, potentially improving future margins.

• Management expects to restart biodiesel production if feedstock prices normalize, potentially later in 2025 or early 2026, and continues to evaluate the impact of new EPA RFS rules.

• New chemical plant commissioning expected in Q3 2025, enabling backward integration and expanded product capacity.

• Multiple new chemical projects commercialized, with production anticipated by end of Q4 2025 and Q1 2026.

• Continued investment in plant reliability and efficiency during biodiesel downtime.